Korean Circ J.  2020 Jun;50(6):524-526. 10.4070/kcj.2020.0122.

External Electrical Cardioversion is an Easy and Safe Intervention for Rhythm Control in Persistent Atrial Fibrillation

• Kwon CH

• KMID: 2500954
• DOI: http://doi.org/10.4070/kcj.2020.0122

Reference

1. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002; 113:359–364. PMID: 12401529.

2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98:946–952. PMID: 9737513.

3. Kotecha D, Holmes J, Krum H, et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet. 2014; 384:2235–2243. PMID: 25193873.

4. Corley SD, Epstein AE, DiMarco JP, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004; 109:1509–1513. PMID: 15007003.

5. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37:2893–2962. PMID: 27567408.

6. Paul MH, Miller RA. External electrical termination of supraventricular arrhythmias in congenital heart disease. Circulation. 1962; 25:604–609. PMID: 14484484.

7. Son NK, Park JW, Kim M, et al. Efficacy and safety of outpatient clinic-based elective external electrical cardioversion in patients with atrial fibrillation. Korean Circ J. 2020; 50:511–523.

8. Hwang TH, Yu HT, Kim TH, et al. Permanent pacemaker implantations after catheter ablation in patients with atrial fibrillation associated with underlying sinus node dysfunction. Korean Circ J. 2020; 50:346–357. PMID: 31960638.

9. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014; 7:31–38. PMID: 24382410.

10. Park MY, Shim WJ, Shin SH, et al. Structural and functional changes of heart after cardioversion of atrial fibrillation. Korean Circ J. 2003; 33:918–927.